Related references
Note: Only part of the references are listed.Degradation of human collagen isoforms by Clostridium collagenase and the effects of degradation products on cell migration
Lei Shi et al.
INTERNATIONAL WOUND JOURNAL (2010)
Regeneration of the mammalian inner ear sensory epithelium
Dongguang Wei et al.
CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY (2009)
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2009)
Quo vadis, hair cell regeneration?
John V. Brigande et al.
NATURE NEUROSCIENCE (2009)
Gene transfer into guinea pig cochlea using adeno-associated virus vectors
Masaya Konishi et al.
JOURNAL OF GENE MEDICINE (2008)
Advances in molecular and cellular therapies for hearing loss
Michael S. Hildebrand et al.
MOLECULAR THERAPY (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genetic and pharmacological intervention for treatment/prevention of hearing loss
Douglas A. Cotanche
JOURNAL OF COMMUNICATION DISORDERS (2008)
Marker retention in the cochlea following injections through the round window membrane
Alec N. Salt et al.
HEARING RESEARCH (2007)
Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo
Yuhe Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity
Louis B. Cooper et al.
OTOLOGY & NEUROTOLOGY (2006)
Specific and efficient transduction of cochlear inner hair cells with recombinant adeno-associated virus type 3 vector
YH Liu et al.
MOLECULAR THERAPY (2005)
Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea
IM Stone et al.
MOLECULAR THERAPY (2005)
Current development of adeno-associated viral vectors
G Romano
DRUG NEWS & PERSPECTIVES (2005)
Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals
M Izumikawa et al.
NATURE MEDICINE (2005)
Treatment of peripheral sensorineural hearing loss: gene therapy
M Duan et al.
GENE THERAPY (2004)
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
C Burger et al.
MOLECULAR THERAPY (2004)
Dynamics of noise-induced cellular injury and repair in the mouse cochlea
Y Wang et al.
JARO (2002)
Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: Further evidence for topical eardrop ototoxicity
DM Kaplan et al.
LARYNGOSCOPE (2002)
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity
N Kaludov et al.
JOURNAL OF VIROLOGY (2001)
A specific promoter of the sensory cells of the inner ear defined by transgenesis
B Boëda et al.
HUMAN MOLECULAR GENETICS (2001)
Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer
AE Luebke et al.
HUMAN GENE THERAPY (2001)
Cochlear gene delivery through an intact round window membrane in mouse
J Jero et al.
HUMAN GENE THERAPY (2001)
Limited proteolysis of the coxsackievirus and adenovirus receptor (CAR) on HeLa cells exposed to trypsin
SD Carson
FEBS LETTERS (2000)
Canine adenovirus type 2 attachment and internalization: Coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway
C Soudais et al.
JOURNAL OF VIROLOGY (2000)
Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity
M Suzuki et al.
GENE THERAPY (2000)
The interaction of heparin sulfate and adeno-associated virus 2
JM Qiu et al.
VIROLOGY (2000)